Table of Contents Author Guidelines Submit a Manuscript
Neurology Research International
Volume 2017, Article ID 8652463, 7 pages
https://doi.org/10.1155/2017/8652463
Research Article

Leptomeningeal Contrast Enhancement Is Associated with Disability Progression and Grey Matter Atrophy in Multiple Sclerosis

1SBIH City Clinical Hospital No. 31, City Center of MS and Autoimmune Diseases, St. Petersburg, Russia
2Neurology Department, FSBEI HE I.P. Pavlov SPbSMU MOH Russia, St. Petersburg, Russia
3Institute of Human Brain of the Russian Academy of Sciences, St. Petersburg, Russia
4Center for Molecular Medicine, Laboratory of Autoimmune Diagnostics, FSBEI HE I.P. Pavlov SPbSMU MOH Russia, St. Petersburg, Russia
5Department of Clinical Pharmacology and EBM, FSBEI HE I.P. Pavlov SPbSMU MOH Russia, St. Petersburg, Russia
6Department of Pharmacoepidemiology and Biostatistics, FSBEI HE I.P. Pavlov SPbSMU MOH Russia, St. Petersburg, Russia
7Institute of Experimental Medicine, St. Petersburg, Russia

Correspondence should be addressed to Gleb Makshakov; moc.liamg@vokahskam.belg

Received 1 May 2017; Revised 7 August 2017; Accepted 24 August 2017; Published 2 October 2017

Academic Editor: Changiz Geula

Copyright © 2017 Gleb Makshakov et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Di Filippo, V. Anderson, D. Altmann et al., “Brain atrophy and lesion load measures over 1 year relate to clinical status after 6 years in patients with clinically isolated syndromes,” Journal of Neurology, Neurosurgery & Psychiatry, vol. 81, no. 2, pp. 204–208, 2009. View at Google Scholar
  2. C. M. Dalton, D. T. Chard, G. R. Davies et al., “Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes,” Brain, vol. 127, no. 5, pp. 1101–1107, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. L. K. Fisniku, D. T. Chard, J. S. Jackson et al., “Gray matter atrophy is related to long-term disability in multiple sclerosis,” Annals of Neurology, vol. 64, no. 3, pp. 247–254, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Calabrese, M. A. Rocca, M. Atzori et al., “A 3-year magnetic resonance imaging study of cortical lesions in relapse-onset multiple sclerosis,” Annals of Neurology, vol. 67, no. 3, pp. 376–383, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Kutzelnigg, C. F. Lucchinetti, C. Stadelmann et al., “Cortical demyelination and diffuse white matter injury in multiple sclerosis,” Brain, vol. 128, no. 11, pp. 2705–2712, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. B. Serafini, B. Rosicarelli, R. Magliozzi, E. Stigliano, and F. Aloisi, “Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis,” Brain Pathology, vol. 14, no. 2, pp. 164–174, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. R. Magliozzi, O. Howell, A. Vora et al., “Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology,” Brain, vol. 130, no. 4, pp. 1089–1104, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. O. W. Howell, C. A. Reeves, R. Nicholas et al., “Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis,” Brain, vol. 134, no. 9, pp. 2755–2771, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. R. Zivadinov, D. P. Ramasamy, M. Vaneckova et al., “Leptomeningeal contrast enhancement is associated with progression of cortical atrophy in MS: A retrospective, pilot, observational longitudinal study,” Multiple Sclerosis Journal, vol. 23, no. 10, pp. 1336–1345, 2016. View at Publisher · View at Google Scholar
  10. A. Mamouriam, P. Hoopes, and L. Lewis, “Visualization of Intravenously Administered Contrast Material in the CSF on Fluid-Attenuated Inversion-Recovery MR Images: an in vitro and animal-model investigation,” AJNR Am J Neuroradiol, vol. 21, pp. 105–111, 2000. View at Google Scholar
  11. M. Absinta, L. Vuolo, A. Rao et al., “Gadolinium-based MRI characterization of leptomeningeal inflammation in multiple sclerosis,” Neurology, vol. 85, no. 1, pp. 18–28, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. P. Eisele, M. Griebe, K. Szabo et al., “Investigation of leptomeningeal enhancement in MS: A postcontrast FLAIR MRI study,” Neurology, vol. 84, no. 8, pp. 770–775, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. R. H. S. R. Roxburgh, S. R. Seaman, T. Masterman et al., “Multiple sclerosis severity score: using disability and disease duration to rate disease severity,” Neurology, vol. 64, no. 7, pp. 1144–1151, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. C. H. Polman, S. C. Reingold, B. Banwell et al., “Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria,” Annals of Neurology, vol. 69, no. 2, pp. 292–302, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. S. M. Smith, Y. Zhang, M. Jenkinson et al., “Accurate, robust, and automated longitudinal and cross-sectional brain change analysis,” NeuroImage, vol. 17, no. 1, pp. 479–489, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. G. Makshakov, V. Nazarov, O. Kochetova, E. Surkova, S. Lapin, and E. Evdoshenko, “Diagnostic and prognostic value of the cerebrospinal fluid concentration of immunoglobulin free light chains in clinically isolated syndrome with conversion to multiple sclerosis,” PLoS ONE, vol. 10, no. 11, Article ID e0143375, 2015. View at Publisher · View at Google Scholar · View at Scopus